Sensitivity of three antibody assays to SARS-CoV-2 nucleocapsid protein in relation to timing since diagnosis
GHM Open · 2022
DOI: 10.35772/ghmo.2021.01030 ↗Kurz gefasst
Fachartikel in der Zeitschrift GHM Open, 2022. Verfasst von Tetsuya Mizoue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyko, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyko, Japan.
- Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
- Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Zitieren
APA
Mizoue, T., Yamamoto, S., Tanaka, A., Oshiro, Y., Inamura, N., Konishi, M., Ozeki, M., & Ohmagari, N. (2022). Sensitivity of three antibody assays to SARS-CoV-2 nucleocapsid protein in relation to timing since diagnosis. GHM Open. https://doi.org/10.35772/ghmo.2021.01030
Vancouver
Mizoue T, Yamamoto S, Tanaka A, Oshiro Y, Inamura N, Konishi M, et al. Sensitivity of three antibody assays to SARS-CoV-2 nucleocapsid protein in relation to timing since diagnosis. GHM Open. 2022. doi:10.35772/ghmo.2021.01030
BibTeX
@article{Mizoue2022,
author = {Mizoue, Tetsuya and Yamamoto, Shohei and Tanaka, Akihito and Oshiro, Yusuke and Inamura, Natsumi and Konishi, Maki and Ozeki, Mitsuru and Ohmagari, Norio},
title = {Sensitivity of three antibody assays to SARS-CoV-2 nucleocapsid protein in relation to timing since diagnosis},
journal = {GHM Open},
year = {2022},
doi = {10.35772/ghmo.2021.01030}
}
EUVIMED